Transient adverse events after REGN-CoV2 administration for mild COVID-19 patients and their potential predictive factors: a single center analysis

enthalten in: bioRxiv.org | 2021

by Kano, G. | Taniguchi, K. | Oue, Y.

Impact of dexamethasone on persistent symptoms of COVID-19: an observational study

enthalten in: bioRxiv.org | 2021

by Milne, A. | Maskell, S. | Sharp, C. | +2

Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis

enthalten in: bioRxiv.org | 2021

by Lee, T. | Bortolussi-Courval, Ã. | Belga, S. | +5

PBPK modelling of dexamethasone in patients with COVID-19 and liver disease

enthalten in: bioRxiv.org | 2021

by Montanha, M. | Cottura, N. | Booth, M. | +7

Baricitinib plus Standard of Care for Hospitalised Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomised, Placebo-Controlled Trial

enthalten in: bioRxiv.org | 2021

by Ely, E. | Ramanan, A. | Kartman, C. | +7

Severity and inpatient mortality of COVID-19 pneumonia from Beta variant infection: a clinical cohort study in Cape Town, South Africa

enthalten in: bioRxiv.org | 2021

by Boloko, L. | Lifson, A. | Little, F. | +16

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

enthalten in: bioRxiv.org | 2021

by Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19

enthalten in: bioRxiv.org | 2021

by Baker, J. | Mahdi, M. | Nicolau, D. | +7

Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19

enthalten in: bioRxiv.org | 2021

by Wang, J. | Levi, J. | Ellis, L. | +1

The association between immunosuppressants use and COVID-19 adverse outcomes: National COVID-19 cohort in South Korea

enthalten in: bioRxiv.org | 2021

by Shin, H. | Chow, R. | Noh, H. | +3